CILIBRIZZI, AGOSTINO
CILIBRIZZI, AGOSTINO
Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA)
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists.
2016 Vergelli, C; Schepetkin, I.A; Ciciani, G; Cilibrizzi, A; Crocetti, L; Giovannoni, M.P; Guerrini, G; Iacovone, A; Kirpotina, L.N; Khlebnikov, A.I; Ye, R.D; Quinn, M.T.
A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex
2018 Ferraro G.; Marzo T.; Infrasca T.; Cilibrizzi A.; Vilar R.; Messori L.; Merlino A.
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
2022 Crocetti, Letizia; Floresta, Giuseppe; Cilibrizzi, Agostino; Giovannoni, Maria Paola
Design, synthesis and pharmacological evaluationof new heterocyclic ligands ofFormyl Peptide Receptors, potentially useful asanalgesic and anti-inflammatory agents
2010 A. Cilibrizzi
Editorial: Serine protease inhibitors and their therapeutic applications
2022 Crocetti, Letizia; Quinn, Mark T; Cilibrizzi, Agostino; Giovannoni, Maria Paola
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists
2021 Vergelli C.; Khlebnikov A.I.; Crocetti L.; Guerrini G.; Cantini N.; Kirpotina L.N.; Schepetkin I.A.; Cilibrizzi A.; Quinn M.T.; Rossi P.; Paoli P.; Giovannoni M.P.
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists
2013 A. Cilibrizzi; L. Crocetti; M.P. Giovannoni; A. Graziano; C. Vergelli; G. Bartolucci; G. Soldani; M.T. Quinn; I.A. Schepetkin; C. Faggi.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. | 2016 | Vergelli, C; Schepetkin, I.A; Ciciani, G; Cilibrizzi, A; Crocetti, L; Giovannoni, M.P; Guerrini, G; Iacovone, A; Kirpotina, L.N; Khlebnikov, A.I; Ye, R.D; Quinn, M.T. | |
| A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex | 2018 | Ferraro G.; Marzo T.; Infrasca T.; Cilibrizzi A.; Vilar R.; Messori L.; Merlino A. | |
| An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022 | 2022 | Crocetti, Letizia; Floresta, Giuseppe; Cilibrizzi, Agostino; Giovannoni, Maria Paola | |
| Design, synthesis and pharmacological evaluationof new heterocyclic ligands ofFormyl Peptide Receptors, potentially useful asanalgesic and anti-inflammatory agents | 2010 | A. Cilibrizzi | |
| Editorial: Serine protease inhibitors and their therapeutic applications | 2022 | Crocetti, Letizia; Quinn, Mark T; Cilibrizzi, Agostino; Giovannoni, Maria Paola | |
| Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists | 2021 | Vergelli C.; Khlebnikov A.I.; Crocetti L.; Guerrini G.; Cantini N.; Kirpotina L.N.; Schepetkin I.A.; Cilibrizzi A.; Quinn M.T.; Rossi P.; Paoli P.; Giovannoni M.P. | |
| Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists | 2013 | A. Cilibrizzi; L. Crocetti; M.P. Giovannoni; A. Graziano; C. Vergelli; G. Bartolucci; G. Soldani; M.T. Quinn; I.A. Schepetkin; C. Faggi. |